ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia

Neurosci Lett. 2005 Mar 22;377(1):37-9. doi: 10.1016/j.neulet.2004.11.062. Epub 2004 Dec 10.

Abstract

Different studies have investigated the effect of the angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism on the risk of Alzheimer dementia (AD). However, results on the association of the ACE-I allele with AD have been inconclusive. A recent meta-analysis reported an association of the I-allele with the risk of AD. A few small studies also investigated the effect of ACE polymorphism on the risk of vascular dementia (VD). We have investigated the effect of ACE I/D polymorphism in 351 AD and 155 VD patients and 348 healthy controls. We found the I/I genotype to be associated with an increased risk of AD, but not with the risk of VD. Cell-specific effects of ACE polymorphism are suggested, additional studies on neuronal cells might help to understand the role of this polymorphism in AD.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / enzymology
  • Alzheimer Disease / genetics*
  • DNA Transposable Elements / genetics
  • Dementia, Vascular / enzymology
  • Dementia, Vascular / genetics*
  • Female
  • Gene Deletion*
  • Gene Frequency / genetics
  • Humans
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic / genetics*
  • Risk Factors

Substances

  • DNA Transposable Elements
  • Peptidyl-Dipeptidase A